4.1 Protein Chemistry, Amino Acid Metabolism, and Nitrogen Balance

Proteins are linear polymers of L-$\alpha$-amino acids linked by covalent peptide bonds. Accounting for approximately 16% of total body weight in healthy adults, proteins are continuously synthesized, degraded, and remodeled through protein turnover. Unlike carbohydrates and lipids, the human body lacks an inert storage depot for protein; every gram of body protein fulfills an active structural, catalytic, transport, or immunological role. Consequently, uncompensated protein loss directly compromises physiological reserves, immune competence, and wound healing.

---

Amino Acid Structure and Classification

Each amino acid possesses a central chiral $\alpha$-carbon bonded to four distinct chemical groups: a basic amino group ($-NH_2$), an acidic carboxyl group ($-COOH$), a hydrogen atom ($-H$), and a variable side chain ($-R$ group) that confers unique chemical properties.

Indispensable, Dispensable, and Conditionally Indispensable Amino Acids

In nutritional science, amino acids are categorized based on the human body's capacity for de novo synthesis:

• Indispensable (Essential) Amino Acids (9): Amino acids whose carbon skeletons cannot be synthesized by human metabolic pathways at rates commensurate with physiological needs. They must be supplied preformed in the diet: Histidine, Isoleucine, Leucine, Lysine, Methionine, Phenylalanine, Threonine, Tryptophan, and Valine (mnemonic: PVT TIM HaLL).
• Dispensable (Non-essential) Amino Acids (5): Synthesized endogenously from central metabolic intermediates (pyruvate, oxaloacetate, $\alpha$-ketoglutarate, 3-phosphoglycerate): Alanine, Asparagine, Aspartate, Glutamate, and Serine.
• Conditionally Indispensable Amino Acids (6): Normally synthesized endogenously in adequate amounts, but synthesis becomes rate-limiting during periods of severe physiological stress, prematurity, trauma, sepsis, or organ failure:
  • Arginine: Becomes essential during rapid neonatal growth, severe sepsis, and wound healing; indispensable for nitric oxide synthesis and urea cycle intermediate flow.
  • Cysteine: Synthesized from methionine; becomes essential in premature neonates or patients with hepatic cirrhosis due to low cystathionine $\beta$-synthase and cystathionase activity.
  • Glutamine: The primary respiratory fuel for rapidly dividing enterocytes, colonocytes, and lymphocytes. Under catabolic stress (major thermal burns, polytrauma, critical illness), muscular glutamine stores are rapidly exhausted, impairing gut barrier function and systemic immunity unless supplied exogenously.
  • Glycine: Becomes rate-limiting in severe burn injuries for collagen synthesis and glutathione conjugation.
  • Proline: Essential during massive tissue rebuilding and wound remodeling for collagen triple-helix hydroxylation.
  • Tyrosine: Synthesized by the hydroxylation of phenylalanine via phenylalanine hydroxylase (PAH). In patients with Phenylketonuria (PKU), an inherited deficiency of PAH renders tyrosine strictly indispensable, requiring medical nutrition therapy with phenylalanine-free, tyrosine-supplemented medical foods.

Specialized Functional Amino Acid Groups

• Branched-Chain Amino Acids (BCAAs): Leucine, Isoleucine, and Valine. Unlike most amino acids, BCAAs escape extensive first-pass hepatic metabolism because the liver possesses very low activity of mitochondrial branched-chain aminotransferase (BCAT). Instead, BCAAs pass directly into systemic circulation and are catabolized predominantly in skeletal muscle, heart, and adipose tissue.
  • Molecular Signaling Role of Leucine: Leucine is not merely a protein substrate; it acts as a direct, potent nutrient secretagogue and molecular trigger that stimulates the mTORC1 (mechanistic target of rapamycin complex 1) kinase signaling cascade via the Sestrin2 sensor. This phosphorylates p70S6 kinase and 4E-BP1, initiating ribosomal translation and stimulating muscle protein synthesis (MPS).
  • Maple Syrup Urine Disease (MSUD): An autosomal recessive defect in the branched-chain $\alpha$-keto acid dehydrogenase (BCKDH) multi-enzyme complex leads to toxic accumulation of BCAAs and their branched-chain $\alpha$-keto acids, causing severe neurotoxicity, encephalopathy, cerebral edema, and a characteristic maple syrup odor in urine and cerumen.
• Aromatic Amino Acids (AAAs): Phenylalanine, Tyrosine, and Tryptophan. Catabolized almost exclusively in the liver. In severe liver cirrhosis or fulminant hepatic failure, hepatic clearance of AAAs is severely impaired, while peripheral hyperinsulinemia promotes muscle uptake of BCAAs. This significantly lowers the Fischer Ratio (the molar ratio of BCAAs to AAAs: $\frac{[Leu + Ile + Val]}{[Phe + Tyr + Trp]}$) from a normal value of $> 3.0$ down to $< 1.0$. The excess circulating AAAs cross the blood-brain barrier via the large neutral amino acid transporter 1 (LAT1), flooding the central nervous system and generating false neurotransmitters (octopamine, phenylethanolamine) that displace dopamine and norepinephrine, exacerbating hepatic encephalopathy.
• Sulfur-Containing Amino Acids: Methionine and Cysteine. Methionine is converted to S-adenosylmethionine (SAMe), the universal methyl donor for DNA methylation, creatine synthesis, and phosphatidylcholine production, yielding homocysteine. Elevated homocysteine is an independent cardiovascular biomarker regulated by remethylation (requiring Vitamin $B_{12}$ and folate) or transsulfuration to cysteine (requiring Vitamin $B_6$).

---

Protein Quality Evaluation

Protein quality reflects the capacity of a dietary protein to satisfy metabolic nitrogen and indispensable amino acid requirements for tissue maintenance, growth, and repair.

The Shift from PDCAAS to DIAAS

The Protein Digestibility-Corrected Amino Acid Score (PDCAAS) was adopted by FAO/WHO in 1991. However, PDCAAS suffers from two major physiological flaws:

1. Fecal vs. Ileal Digestibility: PDCAAS measures protein disappearance over the entire gastrointestinal tract (fecal analysis). Colonic microbiota ferment undigested protein into ammonia and bacterial biomass, falsely elevating apparent digestibility.
2. Truncation at 1.00: Any protein with an amino acid score exceeding 1.00 is arbitrarily truncated to 1.00 (e.g., whey, casein, egg white, and soy protein isolate all score 1.00). This prevents clinicians from evaluating the superior capacity of high-quality animal proteins to supplement lower-quality plant proteins.

To overcome these deficits, the FAO introduced the Digestible Indispensable Amino Acid Score (DIAAS) in 2013:

• Measures individual amino acid digestibility at the terminal ileum before colonic microflora can distort nitrogen balance.
• Values are not truncated, allowing scores above 100% (e.g., milk protein concentrate scores 115–130%, whey isolate scores ~125%, soy isolate scores ~90%, pea protein scores ~82%, and cooked polished rice scores ~60%).

Mutual Supplementation (Protein Complementation)

Plant proteins often contain a limiting amino acid—an indispensable amino acid present in the lowest concentration relative to human requirements:

• Grains and Cereals (Rice, Wheat, Corn): Limited in Lysine and Threonine, but rich in Methionine and Cysteine.
• Legumes and Pulses (Beans, Lentils, Mung Beans / Munggo): Limited in Methionine and Cysteine, but rich in Lysine.
• Clinical Application: Combining complementary plant proteins within the same day—such as the classic Filipino dish ginisang munggo at kanin (mung bean soup with rice)—allows the surplus amino acids of one food to compensate for the deficiencies of the other, achieving a high combined biological value without consuming animal products.

---

Protein Digestion, Zymogen Cascades, and Epithelial Absorption

                         Dietary Protein
                               │
                               ▼ [Gastric Phase: HCl (Parietal cells) denatures protein]
                               ▼ [Pepsinogen (Chief cells) cleaved by HCl to Pepsin]
                    Large Polypeptides & Oligopeptides
                               │
                               ▼ [Duodenal Phase: Chyme stimulates Secretin & CCK]
                    Duodenal Mucosal Enteropeptidase (Enterokinase)
                               │
                               ▼ [Cleaves Trypsinogen to Trypsin]
                      Active Pancreatic Trypsin
                               │
         ┌─────────────────────┼─────────────────────┐
         ▼                     ▼                     ▼
   Chymotrypsinogen        Proelastase        Procarboxypeptidases A & B
         │                     │                     │
         ▼                     ▼                     ▼
    Chymotrypsin            Elastase           Carboxypeptidases A & B
         │                     │                     │
         └─────────────────────┼─────────────────────┘
                               │
                               ▼
                    Small Peptides & Free Amino Acids
                               │
             ┌─────────────────┴─────────────────┐
             ▼                                   ▼
   [PEPT1: H+-Dependent Symport]       [Na+-Dependent AA Transporters]
       Di- and Tripeptides                    Free Amino Acids
             │                                   │
             ▼ [Cytosolic Peptidases]            │
             └─────────────────┬─────────────────┘
                               │
                               ▼
                   Free Amino Acids in Enterocyte
                               │
                               ▼ [Basolateral Transporters: Facilitated Diffusion]
                       Portal Venous Blood

Gastric Phase of Digestion

1. Hydrochloric Acid (HCl): Secreted by gastric parietal cells (stimulated by gastrin, histamine, and acetylcholine). Gastric acid lowers intraluminal pH to 1.5–2.5, denaturing the tertiary and quaternary structures of globular proteins and uncoiling polypeptide chains to expose peptide bonds.
2. Pepsin Activation: Chief cells secrete the inactive zymogen pepsinogen. Below pH 3.0, auto-activation cleaves an N-terminal peptide, releasing active pepsin, an endopeptidase that hydrolyzes peptide bonds involving hydrophobic and aromatic amino acids (phenylalanine, tyrosine, tryptophan, leucine).

Pancreatic Phase and the Enterokinase Master Switch

Upon entering the duodenum, acidic chyme stimulates mucosal S-cells to secrete secretin (triggering pancreatic bicarbonate release to neutralize acid) and I-cells to secrete cholecystokinin (CCK) (triggering pancreatic acinar enzyme secretion):

• Enteropeptidase (Enterokinase): An integral brush border enzyme synthesized by duodenal mucosal cells. Enterokinase recognizes a specific Asp-Asp-Asp-Asp-Lys sequence on the inactive zymogen trypsinogen, cleaving an N-terminal hexapeptide to generate active trypsin.
• Trypsin Auto-Amplification Cascade: Active trypsin serves as the physiological "master key" that autocatalytically activates remaining trypsinogen and cleaves other pancreatic zymogens:
  • Chymotrypsinogen $\to$ Chymotrypsin (endopeptidase cleaving bonds at carboxyl ends of aromatic amino acids).
  • Proelastase $\to$ Elastase (endopeptidase cleaving bonds adjacent to small aliphatic residues like alanine, glycine, serine).
  • Procarboxypeptidases A and B $\to$ Carboxypeptidases A and B (zinc-dependent exopeptidases cleaving single amino acids from the C-terminus).

Enterocyte Absorption: The PEPT1 Advantage

Proteolytic digestion yields approximately 70% small oligopeptides (di- and tripeptides) and 30% free amino acids:

• PEPT1 (Peptide Transporter 1): Located on the apical enterocyte membrane, PEPT1 transports dipeptides and tripeptides via an electrogenic $H^+$-coupled symport mechanism, driven by an apical proton gradient generated by the $Na^+/H^+$ exchanger (NHE3). Small peptides are absorbed substantially faster and with greater kinetic efficiency than an equimolar mixture of free amino acids—a principle utilized in designing semi-elemental peptide-based enteral nutrition formulas for malabsorptive patients.
• Once inside the enterocyte cytoplasm, active cytosolic peptidases rapidly hydrolyze di- and tripeptides into free amino acids.
• Free amino acids exit the basolateral membrane via sodium-independent facilitated diffusion transporters (such as LAT1, System L, and System y+L) into the portal circulation heading directly to the liver.

---

Transamination, Deamination, and the Urea Cycle

Amino acid catabolism requires the separation of the $\alpha$-amino group from the carbon skeleton. The carbon skeletons enter the citric acid cycle as glucogenic intermediates (pyruvate, $\alpha$-ketoglutarate, succinyl-CoA, fumarate, oxaloacetate) or ketogenic precursors (acetoacetyl-CoA, acetyl-CoA). The removed nitrogen must be safely detoxified.

Transamination

Transamination is the reversible transfer of an $\alpha$-amino group from an amino acid to an $\alpha$-keto acid (most commonly $\alpha$-ketoglutarate), generating the corresponding $\alpha$-keto acid of the original amino acid and L-glutamate.

• Cofactor: All aminotransferases (transaminases) require pyridoxal-5'-phosphate (PLP), the active coenzyme form of Vitamin $B_6$.
• Clinical Biomarkers:
  • Alanine Aminotransferase (ALT / SGPT): $\text{Alanine} + \alpha\text{-Ketoglutarate} \rightleftharpoons \text{Pyruvate} + \text{Glutamate}$. Predominantly cytosolic and localized primarily in hepatocytes; highly specific biomarker for hepatocellular injury.
  • Aspartate Aminotransferase (AST / SGOT): $\text{Aspartate} + \alpha\text{-Ketoglutarate} \rightleftharpoons \text{Oxaloacetate} + \text{Glutamate}$. Both cytosolic and mitochondrial; found in liver, myocardium, skeletal muscle, and kidneys. An AST:ALT ratio $> 2:1$ classically suggests alcoholic liver disease, whereas viral hepatitis typically presents with ALT exceeding AST.
• Exceptions: Lysine and threonine do not participate in transamination reactions.

Oxidative Deamination and Ammonia Transport

• Glutamate Dehydrogenase (GDH): In mitochondrial matrix of hepatocytes, GDH oxidatively deaminates glutamate to release free, toxic ammonium ion ($NH_4^+$) and regenerate $\alpha$-ketoglutarate, utilizing $NAD^+$ or $NADP^+$.
• Peripheral Ammonia Transport: Extrahepatic tissues cannot synthesize urea. Muscle converts excess amino groups to alanine via the glucose-alanine cycle, which is exported to the liver. Brain and peripheral tissues fix toxic ammonia into glutamate via glutamine synthetase to form non-toxic L-glutamine, which travels through the blood to the liver (where glutaminase releases ammonia for urea synthesis) and kidneys (where glutaminase releases $NH_4^+$ into urine to buffer metabolic acids).

The Urea Cycle (Krebs-Henseleit Cycle)

The urea cycle is the exclusive mammalian metabolic pathway for converting neurotoxic ammonia into non-toxic, water-soluble urea for renal clearance. It occurs exclusively in hepatocytes, partitioned across two cellular compartments:

[MITOCHONDRIAL MATRIX]
   NH4+ + HCO3- + 2 ATP
            │
            ▼ ◄─── N-Acetylglutamate (NAG) [Obligate Allosteric Activator]
   [1. Carbamoyl Phosphate Synthetase I (CPS-1)] (Rate-Limiting Step)
            │
   Carbamoyl Phosphate
            │
            ├──────── Ornithine (transported into mitochondria)
            ▼
   [2. Ornithine Transcarbamylase (OTC)]
            │
        Citrulline
            │
            ▼ (Citrulline exported to cytosol via SLC25A15)
─────────────────────────────────────────────────────────────────────────────
[CYTOSOL]
        Citrulline + Aspartate + ATP (Provides second nitrogen)
            │
            ▼
   [3. Argininosuccinate Synthetase (ASS)]
            │
     Argininosuccinate
            │
            ├──────── Fumarate ──► (Enters Krebs Cycle: "Krebs Bicycle")
            ▼
   [4. Argininosuccinate Lyase (ASL)]
            │
        L-Arginine + H2O
            │
            ▼
   [5. Arginase-1 (ARG1)]
            │
            ├──────── UREA (diffuses to blood ──► excreted in urine)
            ▼
        Ornithine (transported back into mitochondria)

1. Carbamoyl Phosphate Synthetase I (CPS-1): Located in the mitochondrial matrix; catalyzes the condensation of $NH_4^+$, $HCO_3^-$, and 2 ATP to form carbamoyl phosphate. This is the rate-limiting step of the urea cycle. CPS-1 is inactive unless allosterically bound by N-acetylglutamate (NAG). NAG is synthesized from glutamate and acetyl-CoA by NAG synthase, an enzyme allosterically stimulated by arginine.
2. Ornithine Transcarbamylase (OTC): Mitochondrial; transfers a carbamoyl group from carbamoyl phosphate to ornithine, generating citrulline. OTC deficiency is the most common inherited urea cycle disorder, inherited as an X-linked recessive trait, leading to severe hyperammonemia, respiratory alkalosis, and orotic aciduria.
3. Argininosuccinate Synthetase (ASS): Cytosolic; condenses citrulline with aspartate (consuming 2 ATP equivalents, forming AMP and $PP_i$). This step incorporates the second nitrogen atom of the urea molecule.
4. Argininosuccinate Lyase (ASL): Cytosolic; cleaves argininosuccinate into L-arginine and fumarate. Fumarate enters the citric acid cycle, linking both cycles in the "Krebs bicycle."
5. Arginase-1 (ARG1): Cytosolic; hydrolyzes arginine to form urea and regenerate ornithine. Ornithine is shuttled back into the mitochondria via the ORNT1 transporter to initiate another round of the cycle.

---

Nitrogen Balance Assessment in Clinical Dietetics

Nitrogen balance ($NB$) is the gold standard clinical method for evaluating the adequacy of dietary protein intake and determining whole-body catabolic versus anabolic status in hospitalized, critically ill, and outpatient populations.

The Nitrogen Factor and Biological Basis

On average, dietary proteins contain 16% nitrogen by weight ($100\text{ g protein} / 16\text{ g nitrogen} = 6.25$). Thus, dividing protein intake in grams by 6.25 yields total nitrogen intake:

$\text{Nitrogen Intake (g)} = \frac{\text{Protein Intake (g)}}{6.25}$

Clinical Nitrogen Balance Formula

Nitrogen output is determined by analyzing a 24-hour urine collection for Urinary Urea Nitrogen (UUN), adding a standard correction factor of 4 grams to account for non-urea urinary nitrogen losses and insensible losses:

$\text{NB (g/day)} = \text{Nitrogen Intake} - \text{Nitrogen Output}$ $\text{NB} = \frac{\text{Protein Intake (g)}}{6.25} - \left( \text{UUN (g/day)} + 4\text{ g} \right)$

Where the $+4\text{ g}$ constant comprises:

• $2\text{ g}$: Non-urea urinary nitrogen losses (creatinine, uric acid, free amino acids, ammonium ions).
• $2\text{ g}$: Fecal nitrogen and insensible integumentary losses (desquamated skin cells, sweat, shed hair, and nails).

Clinical Interpretation of Nitrogen Balance States

• Equilibrium ($\text{NB} \approx 0\text{ g/day}$, typically $-1\text{ to }+1\text{ g}$): Reflects homeostatic maintenance in healthy adults, where protein synthesis equals protein breakdown.
• Positive Nitrogen Balance ($\text{NB} > +2\text{ g/day}$): Nitrogen intake exceeds nitrogen excretion, indicating net protein accretion and tissue anabolism. Observed in normal infant and childhood growth, pregnancy, lactation, athletic muscle hypertrophy, and recovery/repletion from illness or starvation.
• Negative Nitrogen Balance ($\text{NB} < -2\text{ g/day}$): Nitrogen excretion exceeds intake, indicating net lean tissue breakdown and muscle wasting. Observed in critical illness, severe thermal burns, polytrauma, untreated sepsis, prolonged starvation, uncontrolled Cushing's syndrome, and cancer cachexia.

Step-by-Step Clinical Calculation Scenario

A 45-year-old male polytrauma patient weighing 70 kg in the surgical intensive care unit receives a specialized enteral nutrition formulation providing 90 grams of intact protein over a 24-hour period. A concurrent 24-hour urine collection reveals a Urinary Urea Nitrogen (UUN) excretion of 14.4 grams. Calculate the patient's nitrogen balance and interpret the clinical result:

1. Calculate Nitrogen Intake: $\text{Nitrogen Intake} = \frac{90\text{ g protein}}{6.25} = 14.40\text{ g N}$
2. Calculate Total Nitrogen Output: $\text{Nitrogen Output} = \text{UUN} + 4 = 14.40\text{ g} + 4.0\text{ g} = 18.40\text{ g N}$
3. Calculate Nitrogen Balance: $\text{NB} = 14.40\text{ g} - 18.40\text{ g} = -4.00\text{ g N/day}$
4. Clinical Interpretation: The patient is in a marked negative nitrogen balance ($-4.0\text{ g N/day}$), representing a net daily loss of approximately $4.0 \times 6.25 = 25\text{ grams of functional body protein}$, or roughly $100–125\text{ grams of wet muscle tissue}$ per day. The clinical dietitian must uptitrate protein delivery (e.g., targeting 1.5–2.0 g/kg/day, or 105–140 g protein) alongside adequate non-protein calories to suppress gluconeogenic muscle proteolysis.